Penn Medicine Physician Interviews

Ty Dunn MD, MS discusses simultaneous pancreas-kidney (SPK) transplant. She emphasizes the relationship between type 1 diabetes and the destruction of these organs as well as the indications for both pancreas transplantation alone and SPK transplant. She shares the differences in the outcomes for SPK transplant versus pancreas-alone, or pancreas after kidney transplant and she tells us about the new allocation policies for kidney and pancreas transplantation. Lastly, she offers the recommendations for timing of referral for SPK transplant evaluation, and the advantages for individuals considering Penn Medicine’s Kidney and Pancreas Transplant program.

Donald O'Rourke, MD, discusses the microenvironment of glioblastomas, Penn's upcoming clinical trial for recurrent glioblastoma multiforme (GBM) and his outlook on the future research for GBM.

Nicole Saur, MD, discusses the launch of the PeRioperative Evaluation and Planning (PREP) Program at Penn Medicine and the PREP Program's multidisciplinary, multiphase approach for optimization of older patients undergoing colorectal surgery.

Noam Cohen, MD, PhD, discusses the role of taste receptors in the nose, the disease implications of these taste receptors, and his team's research on modulating taste receptors to treat chronic rhinosinusitis.

Neil Taunk, MD, MSCTS, discusses Penn Medicine's high-dose rate brachytherapy, a new offering from Penn Medicine.

Joshua Levine, MD, discusses the internationally recognized Penn Neurocritical Care Program, the multidisciplinary treatment team and the advanced technology that is individualizing patient care at Penn Medicine.

Julia Glaser, MD, discusses the role of vascular surgery in critical limb ischemia treatment — the mission of the Penn Advanced Limb Preservation (PALP) Program, the population treated for critical limb ischemia, and how the PALP program utilizes multidisciplinary teams.

Cara A. Cipriano, MD, MSc, Chief of Orthopaedic Oncology and Associate Professor of Orthopaedic Surgery, discusses her role at Penn Medicine and her commitment to diversify the field of orthopaedics.

Roger Cohen, MD, and Donald Siegel, MD, PhD, discuss the enrolling novel CAR T-Cell medullary thyroid cancer clinical trial at Penn Medicine, and which patients should participate in the clinical trial.

In this engaging interview, Rhondalyn McLean, MD, reviews the evolution of heart transplantation in the U.S. and at Penn Medicine, including indications, the importance of early referral, and long-term survival. She also examines recent transplant allocation changes and how Penn Medicine is working to expand the donor pool, including transplanting hearts from individuals with hepatitis C.